RVC August 2026 Investor Forum & Happy Hour

RVC August 2026 Investor Forum

Hosted at Foley & Lardner (1144 15th St Suite 2200, Denver, CO 80202)

RVC Investor Forums bring together accredited angel investors interested in fast-growing, early-stage companies in Colorado. These forums serve to pool the wisdom, expertise, and capital of many individual angels. At this forum, investor members will hear pitches, and afterwards the founders are excused and investors discuss the merits and risks of each venture. There is no requirement to invest and each investor has an opportunity to indicate interest in following or leading a specific deal. Both new and experienced investor members are welcome at forums -- this is the best way to learn hands-on about angel investing! 

Meeting Agenda:

Welcome and Introductions

3:00pm to 3:15 pm

Deal-in-Play Discussion

3:15pm to 3:30pm

3:30 pm to 4:15pm

Investor Only Discussion

4:15 to 5:00pm

Investor Social

5:00 to 7:00pm

Presenting Companies

Galaxy Diagnostics is solving a problem the diagnostics industry has quietly lived with for decades: the CDC recommended two-tier antibody test misses 77% of early Lyme infections. Galaxy replaces that indirect approach with direct detection, confirming the presence of infection even when standard serology comes back negative - and the technology is already commercial. Galaxy's urine antigen test for Lyme Borrelia and its Digital PCR panel for Bartonella, Babesia, and Borrelia run today in Galaxy's own CLIA-certified lab, and lab revenue doubled to $1.4M in 2025 at 70–86% gross margins. The next step is scale: FDA-cleared kits and distribution through national reference laboratories, turning a validated diagnostic edge into a mainstream standard of care. 

WarpWare is building and commercializing the necessary software layer to help get payloads and vehicles to space fast. We're just wrapping up our oversubscribed pre-seed round and already have strong traction with several space companies (OrbitFab, Argotec, LEAP built and flew their Bullfrog rocket on it) and are quickly expanding to include even more companies (Constellation Space, Cowboy Space, Intuitive Machines, etc.) Our platform helps companies move from design through development to operations, leveraging an AI-enabled layer that makes teams much more efficient (Mission Planning demo here). WarpWare will become a one-stop shop for companies to design space missions, select and buy hardware, book launches, and operate their vehicles. 

PharmaJet is capitalizing on its IP and established needle-free fluid injection platforms (used for vaccine and therapeutic administration) to develop a needle-free subcutaneous self-administration drug delivery platform ("NF Pen"). Designed with features for weekly use for chronic disease patients self-administering, the NF Pen will be co-developed with specific drug indications to serve a needle-phobic/hesitant/non-adherent patient audience, where needles have been proven to be problematic for patients. With $2m closed in a spin-out structure, the Convertible Note is open for small investors (existing and new RVC investors), while a larger fundraising is now underway, in tandem with active engagement with pharma partners for specific drug indications positively advancing.

To attend this event, you must be accredited: Net worth of at least one million US dollars, not including the value of one’s primary residence, or have made at least $200,000 each year for the last two years [or $300,000 if jointly filing] and have the expectation to make the same amount this year. We do not require a minimum investment.